{"effective_time":"20251117","id":"eb52b342-1672-42e7-bb4c-9c8f1bce7fc3","openfda":{"application_number":["ANDA206318"],"brand_name":["Rivastigmine"],"generic_name":["RIVASTIGMINE"],"is_original_packager":[true],"manufacturer_name":["Zydus Lifesciences Limited"],"nui":["N0000175723","N0000000177"],"package_ndc":["70771-1949-1","70771-1949-7","70771-1950-1","70771-1950-7","70771-1951-1","70771-1951-7"],"pharm_class_epc":["Cholinesterase Inhibitor [EPC]"],"pharm_class_moa":["Cholinesterase Inhibitors [MoA]"],"product_ndc":["70771-1949","70771-1950","70771-1951"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TRANSDERMAL"],"rxcui":["725021","725023","1308569"],"spl_id":["eb52b342-1672-42e7-bb4c-9c8f1bce7fc3"],"spl_set_id":["966d59ea-5cea-4fef-8b96-e0efe885caf4"],"substance_name":["RIVASTIGMINE"],"unii":["PKI06M3IW0"]},"package_label_principal_display_panel":["PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Rx only NDC 70771-1949-7 Rivastigmine Transdermal System Each System Delivers 4.6 mg/24 hours For Transdermal Use Only. Contains 30 systems Rx only NDC 70771-1950-7 Rivastigmine Transdermal System Each System Delivers 9.5 mg/24 hours For Transdermal Use Only. Contains 30 systems Rx only NDC 70771-1951-7 Rivastigmine Transdermal System Each System Delivers 13.3 mg/24 hours For Transdermal Use Only. Contains 30 systems 4.6 mg/24 hrs 9.5 mg/24 hrs 13.3 mg/24 hrs"],"set_id":"966d59ea-5cea-4fef-8b96-e0efe885caf4","spl_product_data_elements":["Rivastigmine Rivastigmine RIVASTIGMINE RIVASTIGMINE SILICON DIOXIDE LIGHT MINERAL OIL POLYISOBUTYLENE (1100000 MW) POLYISOBUTYLENE (55000 MW) Rivastigmine Rivastigmine RIVASTIGMINE RIVASTIGMINE SILICON DIOXIDE LIGHT MINERAL OIL POLYISOBUTYLENE (1100000 MW) POLYISOBUTYLENE (55000 MW) Rivastigmine Rivastigmine RIVASTIGMINE RIVASTIGMINE SILICON DIOXIDE LIGHT MINERAL OIL POLYISOBUTYLENE (1100000 MW) POLYISOBUTYLENE (55000 MW)"],"spl_unclassified_section":[""],"version":"1"}